November 16, 2023

Congress passed a two-tiered continuing resolution (CR) on November 15, 2023, extending FY 2023 federal funding levels until February 2, 2024, for all Department of Health and Human Services agencies, including the National Institutes of Health (NIH) and the National Cancer Institute (NCI). The president is expected to sign the bill.

October 17, 2023

The American Society of Clinical Oncology and Association for Clinical Oncology (ASCO) are urging members of the Senate Committee on Health, Education, Labor, and Pensions to approve the nomination of Monica M. Bertagnolli, MD, FACS, FASCO, as the next Director of the National Institutes of Health (NIH) during its October 18, 2023, hearing.

September 28, 2023

ASCO has released a statement on the how an impending government shutdown will impact cancer research and scientific progress.

September 14, 2023

The House Energy and Commerce Subcommittee on Health will hold a hearing today on several bills aimed at addressing the ongoing U.S. drug shortage crisis. Many of the bills contain provisions the Association for Clinical Oncology supports as effective means to mitigate and prevent drug shortages and promote a more resilient supply chain in the future. 

July 7, 2023

The Department of Health and Human Services (HHS), Department of Labor and the Treasury Department issued a proposed rule regulating the availability of short-term limited duration insurance (STLDI) plans. The rule would restrict the availability of these plans to no more than four months. 

May 31, 2023

Today the U.S. House is poised to vote on legislation to raise the nation’s debt ceiling. The proposal includes flat funding for non-defense discretionary spending in FY 2024 and a 1% funding increase in FY 2025. This would considerably restrict potential resources for the National Institutes of Health (NIH) and National Cancer Institute (NCI) at a time when scientists are on the cusp of so many promising cancer discoveries. 

May 1, 2023

ALEXANDRIA, Va. – More than 150 members of the Association of Clinical Oncology (ASCO), the leading professional organization for oncology professionals, will meet with Members of Congress on Tuesday urging them to make cancer care a top priority.

“Lawmakers have a profound effect on cancer patients and their doctors. From funding the research that leads to new groundbreaking treatments, to ensuring those treatments are covered by insurance and accessible and affordable to patients; lawmakers play a pivotal role,” said ASCO Board Chair Lori J. Pierce, MD, FASTRO, FASCO.

April 19, 2023

Today members of the U.S. House of Representatives unveiled a proposed legislative deal to reduce federal spending in exchange for raising the nation’s debt ceiling. The proposal includes significant funding cuts to federal agencies, which would include resources for the National Institutes of Health (NIH) and National Cancer Institute (NCI). It also proposes adding work requirements for Medicaid enrollment.

A statement from Dr. Julie Gralow, Chief Medical Officer and Executive Vice President, Association of Clinical Oncology follows:

March 23, 2023

Dr. Brian Persing, a medical oncologist and hematologist in Mobile, Alabama and member of the Association of Clinical Oncology (ASCO), the world’s leading professional organization representing nearly 45,000 oncology professionals, will testify before the House Appropriations Subcommittee on Labor Health and Human Services and Education today in support of increased federal funding for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control. He will also advocate for robust funding of the Advanced Research Projects Agency for Health (ARPA-H). 

March 9, 2023

Today President Biden released his proposed Fiscal Year (FY) 2024 federal budget with an emphasis on increased funding for medical research and expanded access to health insurance.

February 8, 2023

“ASCO applauds President Biden’s focus on ‘ending cancer as we know it’ during the State of the Union address. We continue to urge the president to keep cancer care and research as top national priorities and are pleased with his plans to advance efforts to strengthen the Cancer Moonshot, improve cancer clinical trials, and foster breakthroughs through the Advanced Research Projects Agency for Health (ARPA-H).”

 

February 7, 2023

In anticipation of President Biden’s State of the Union Address, the Association for Clinical Oncology (ASCO) is urging the president to keep cancer care and research as top national priorities. 

February 2, 2023

Dedicated to making a world of difference in cancer care, the American Society of Clinical Oncology and its affiliated organization, the American Association of Clinical Oncology (ASCO), laud the goals, progress, and continued potential of the Cancer Moonshot initiative. Having the full support of the President and the resources of the federal government is essential to our shared goal of accelerating the pace of progress against a disease that will be diagnosed in more than 1.9 million people in the U.S. this year.

November 22, 2022

Prior authorization is harming individuals with cancer according to new survey results from the Association for Clinical Oncology (ASCO). The survey found that prior authorization delays necessary care, worsens cancer care outcomes, and diverts clinicians from caring for their patients.

September 12, 2022

“President John F. Kennedy’s historic speech that inspired our nation and an entire generation of Americans to achieve manned space exploration underscored the courage and commitment it would take to accomplish this then-audacious goal: ‘We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard.’

Pages